3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 5.93
-0.06 (-1.00%)
Jul 18, 2025, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 1.45 billion as of July 18, 2025. Its market cap has increased by 2.57% in one year.
Market Cap
1.45B
Enterprise Value
724.03M
Revenue
474.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.93
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 1.45B, a decrease of -79.32%. That is a compound annual growth rate of -45.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1.45B | 92.48% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 259.57B |
| Hansoh Pharmaceutical Group Company | 205.13B |
| Innovent Biologics | 152.31B |
| JD Health International | 149.93B |
| Akeso | 125.21B |
| Sino Biopharmaceutical | 121.97B |
| WuXi Biologics | 115.16B |
| CSPC Pharmaceutical Group | 102.41B |